Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies.
Kodama H, Suzuki M, Katayose Y, Shinoda M, Sakurai N, Takemura S, Yoshida H, Saeki H, Asano R, Ichiyama M, Imai K, Hinoda Y, Matsuno S, Kudo T.
Kodama H, et al. Among authors: kudo t.
Immunol Lett. 2002 Apr 22;81(2):99-106. doi: 10.1016/s0165-2478(01)00343-1.
Immunol Lett. 2002.
PMID: 11852114